Drugs / Freeze-dried Human Rabies Vaccine（Human Diploid Cell）
Freeze-dried Human Rabies Vaccine（Human Diploid Cell）
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07021703 | May → Jul 2025 overdue | rabies | Ningbo Rongan Biological Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Freeze-dried Human Rabies Vaccine（Human Diploid Cell） | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07021703 ↗ |
| Modality | Vaccine | “The Phase 1 clinical trial of the freeze-dried human rabies vaccine (human diploid cells)” NCT07021703 ↗ |